Sleep Information Center
Experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, discuss the connections between obstructive sleep apnea and sudden cardiac death.
Sleep Information Center
The researchers examined the links between pediatric obstructive sleep apnea (OSA) and elevated blood pressure and OSA’s orthostatic reactivity in adolescence.
Sleep Information Center
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Sleep Information Center
There may be increased hospitalization risk from influenza infection in patients with obstructive sleep apnea who do not use continuous positive airway pressure.
Sleep Information Center
Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.
Psych Congress 2020
Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
Sleep Information Center
The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
Sleep Information Center
Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.
Sleep Information Center
Among patients with mild obstructive sleep apnea, quality of life is improved at 3 months for those receiving continuous positive airway pressure therapy plus standard care compared with standard care alone.
News, Sleep Information Center
Increased odds ratios for cancer observed in different categories of OSA for women, not men.
